Bora Pharmaceuticals Co., Ltd. is a pharmaceutical services company. Bora Pharmaceuticals Co., Ltd. is based in MISSISSAUGA, Ontario.
| Revenue (Most Recent Fiscal Year) | $610.75M |
| Net Income (Most Recent Fiscal Year) | $95.70M |
| PE Ratio (Current Year Earnings Estimate) | 19.62 |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.20 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | 14.10% |
| Net Margin (Trailing 12 Months) | 8.42% |
| Return on Equity (Trailing 12 Months) | 12.13% |
| Return on Assets (Trailing 12 Months) | 4.51% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.38 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.12 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.74 |
| Inventory Turnover (Trailing 12 Months) | 3.28 |
| Book Value per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.03 |
| Earnings per Share (Most Recent Fiscal Year) | $0.22 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 640.42M |
| Free Float | -- |
| Market Capitalization | $2.01B |
| Average Volume (Last 20 Days) | 316.40 |
| Beta (Past 60 Months) | -- |
| Percentage Held By Insiders (Latest Annual Proxy Report) | -- |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.03 |
| Dividend Yield (Based on Last Quarter) | 1.11% |